Neoleukin Therapeutics logo
Neoleukin Therapeutics NLTX
$ 3.49 0.0%

Quarterly report 2024-Q3
added 11-18-2024

report update icon

Neoleukin Therapeutics Financial Ratios 2011-2024 | NLTX

Annual Financial Ratios Neoleukin Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

0.1 -0.7 -2.3 -20.5 -4.6 -1.7 -6.1 -9.0 -6.1 -3.8 - - -

P/S

- - - - - 2.1 - - - - - - -

EPS

27.8 -1.0 -1.1 -0.6 -2.6 -1.3 -2.1 -2.0 -1.7 -2.8 -49.5 -40.2 -

EV (Enterprise Value)

-110 M -33.8 M 19.9 M 509 M 180 M -19.3 M 264 M 311 M 98 M 82.3 M -6.12 M 51.4 M -

EBITDA per Share

-106 -0.97 -1.08 -0.879 -0.847 -1.34 -2.14 -1.96 -1.72 -2.57 - - -

EV/EBITDA

0.2 -10.3 -7.6 0.8 -5.0 -8.1 -4.3 -3.5 - - -

PEG

0.0 0.06 0.3 -0.27 0.05 -0.04 0.66 0.68 -0.16 0.05 - - -

P/B

0.0 0.4 1.0 3.6 2.2 0.7 3.1 2.3 1.2 2.5 - - -

P/CF

-0.0 -0.7 -3.0 -25.5 -19.5 -1.7 -6.7 -10.8 -6.5 -5.1 - - -

ROE %

7.34 37.87 -42.48 -17.40 -49.01 -43.46 -50.75 -25.58 -20.16 -66.47 - - -

ROA %

6.13 -50.51 -37.17 -15.81 -47.23 -40.69 -45.48 -23.97 -19.29 -58.00 - - -

ROCE %

-29.88 38.78 -42.49 -20.51 -16.34 -44.70 -51.44 -25.99 -19.66 -61.78 - - -

Current Ratio

6.1 10.3 8.0 24.7 30.3 16.7 9.9 10.9 15.6 7.6 - - -

DSO

- - - - - 3.5 - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Neoleukin Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.19 -1.09 - -32.67 -26.68 -0.26 - -1.18 -0.28 -0.28 - -0.28 -0.27 -0.27 - -0.04 -0.2 -0.18 - -2.26 -0.09 -0.09 - -0.64 0.12 -0.62 - -0.5 -0.59 -0.36 - -0.46 -0.63 -0.39 - -0.43 -0.44 -0.6 - -0.59 -0.51 -1.28 - -15.64 -7.89 -8.48 - - - - - - - -

EBITDA per Share

-1.26 -1.14 - -32.3 -26.5 -0.27 - -1.12 -0.27 -0.27 - -0.26 -0.26 -0.27 - -0.03 -0.19 -0.18 - -2.27 -0.01 - - -0.65 0.11 - - -0.51 -0.6 - - - - - - - - - - - 0.01 0.01 - 0.15 0.05 0.05 - - - - - - - -

ROE %

-10.73 11.00 -2.49 -14.86 -35.19 -55.65 -37.62 -47.59 -45.19 -40.80 -27.38 -28.56 -19.76 -15.80 -10.79 -52.53 -93.08 -87.99 -43.29 -63.92 -42.82 -38.81 -36.74 -48.70 -40.04 -57.98 -34.30 -39.93 -33.59 -27.21 -17.81 -22.45 -21.46 -18.31 -14.94 -32.32 -45.06 -55.69 -44.09 -38.96 -16.45 -0.21 7.90 7.90 2.77 1.54 - - - - - - - -

ROA %

-55.14 -55.44 -43.31 -53.64 -47.70 -46.53 -32.07 -40.85 -39.30 -35.94 -24.34 -25.41 -17.70 -14.24 -9.80 -50.02 -89.17 -84.54 -41.72 -61.04 -40.14 -36.38 -34.40 -45.12 -36.53 -52.77 -30.74 -36.02 -30.57 -25.15 -16.68 -21.13 -20.29 -17.42 -14.29 -29.46 -40.19 -49.09 -38.47 -59.99 -66.34 -58.43 -33.16 -33.16 -11.64 -6.46 - - - - - - - -

ROCE %

-12.52 11.08 -2.85 -15.73 -36.92 -57.97 -38.29 -48.27 -45.36 -40.82 -27.38 -28.56 -19.76 -15.81 -11.03 -53.03 -93.86 -89.06 -42.31 -63.22 -42.13 -38.12 -17.21 -29.42 -20.71 -38.56 -26.36 -26.36 -14.15 - - - - - - - - - - - - - - - - - - - - - - - - -

Current Ratio

6.2 7.2 6.1 6.2 6.5 5.8 5.4 6.0 6.8 7.8 8.0 8.3 9.4 9.5 10.9 10.9 10.9 10.9 27.6 27.6 27.6 27.6 15.7 15.7 15.7 15.7 9.6 9.6 9.6 9.6 15.9 15.9 15.9 15.9 23.0 23.0 23.0 23.0 7.8 7.8 7.8 7.8 2.1 2.1 2.1 2.1 - - - - - - - -

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency